Cargando…

A systematic review and meta-analysis comparing intravitreal ranibizumab with bevacizumab for the treatment of myopic choroidal neovascularisation

Intravitreal injections of ranibizumab (IVR) and bevacizumab (IVB) have both been used as treatments for myopic choroidal neovascularisation. We aimed to produce a meta-analysis of published literature comparing IVR with IVB for the treatment of myopic choroidal neovascularisation, by searching elec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Loutfi, M., Siddiqui, M.R.S., Dhedhi, A., Kamal, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4398811/ https://www.ncbi.nlm.nih.gov/pubmed/25892935 http://dx.doi.org/10.1016/j.sjopt.2014.09.004

Ejemplares similares

Effect of Intravitreal Ranibizumab in the Treatment of Peripapillary Choroidal Neovascularisation
por: Hamoudi, Hassan, et al.
Publicado: (2011)

Single intravitreal ranibizumab for myopic choroidal neovascularization
por: Nor-Masniwati, Saidin, et al.
Publicado: (2011)

Treatment of myopic choroidal neovascularization with intravitreal ranibizumab injections: the role of age
por: Karagiannis, Dimitrios, et al.
Publicado: (2017)

Pilot study of ziv-aflibercept in myopic choroidal neovascularisation patients
por: Nawar, Amin E., et al.
Publicado: (2020)

Comparison of intravitreal bevacizumab and ranibizumab used for myopic choroidal neovascularization: A PRISMA-compliant systematic review and meta-analysis of randomized controlled trials
por: Hu, Qiuming, et al.
Publicado: (2019)

Aflibercept as primary treatment for myopic choroidal neovascularisation: a retrospective study
por: Bruè, C, et al.
Publicado: (2016)

Myopic choroidal neovascularisation: current concepts and update on clinical management
por: Wong, Tien Y, et al.
Publicado: (2015)

Diagnostic accuracy of OCTA and OCT for myopic choroidal neovascularisation: a systematic review and meta-analysis
por: Ho, Sharon, et al.
Publicado: (2022)

Recurrence risk of myopic choroidal neovascularisation: a systematic review of current study
por: Victor, Andi Arus, et al.
Publicado: (2023)

Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
por: Wang, Jia-Kang, et al.
Publicado: (2018)

Intravitreal conbercept for choroidal neovascularisation secondary to pathological myopia in a real‐world setting in China: Intravitreal conbercept was safe and effective in treating myopic choroidal neovascularization
por: Nie, Xin, et al.
Publicado: (2021)

Ranibizumab versus Bevacizumab for Ophthalmic Diseases Related to Neovascularisation: A Meta-Analysis of Randomised Controlled Trials
por: Wu, Bin, et al.
Publicado: (2014)

Combined photodynamic therapy and intravitreal bevacizumab as treatment for nonresponsive myopic choroidal neovascularization
por: Chhablani, Jay Kumar
Publicado: (2010)

Comparative role of intravitreal ranibizumab versus bevacizumab in choroidal neovascular membrane in age-related macular degeneration
por: Biswas, Partha, et al.
Publicado: (2011)

Comparison of Intravitreal Aflibercept and Ranibizumab for Treatment of Myopic Choroidal Neovascularization: One-Year Results—A Retrospective, Comparative Study
por: Erden, Burak, et al.
Publicado: (2019)

Comparison of 1-year therapeutic effect of ranibizumab and bevacizumab for myopic choroidal neovascularization: a retrospective, multicenter, comparative study
por: Cha, Dong Min, et al.
Publicado: (2014)

Ten-Year Outcomes of Intravitreal Bevacizumab for Myopic Choroidal Neovascularization: Analysis of Prognostic Factors
por: Mallone, Fabiana, et al.
Publicado: (2021)

Short-term Effectiveness of Intravitreal Bevacizumab vs. Ranibizumab Injections for Patients with Polypoidal Choroidal Vasculopathy
por: Cho, Han Joo, et al.
Publicado: (2012)

Choroidal thickness after intravitreal ranibizumab injections for choroidal neovascularization
por: Ellabban, Abdallah A, et al.
Publicado: (2012)

SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB
por: Avery, Robert L., et al.
Publicado: (2017)

Intravitreal ranibizumab for treatment of choroidal neovascularization secondary to a bilateral choroidal osteoma
por: Zafar, Sidra, et al.
Publicado: (2016)

Responsiveness of eyes with polypoidal choroidal vasculopathy with choroidal hyperpermeability to intravitreal ranibizumab
por: Sonoda, Shozo, et al.
Publicado: (2013)

Acute anterior uveitis following intravitreal bevacizumab but not subsequent ranibizumab
por: Antonopoulos, Christina, et al.
Publicado: (2011)

Photodynamic monotherapy or combination treatment with intravitreal triamcinolone acetonide, bevacizumab or ranibizumab for choroidal neovascularization associated with pathological myopia
por: Rishi, Pukhraj, et al.
Publicado: (2011)

Neuropilin 1 Involvement in Choroidal and Retinal Neovascularisation
por: Fernández-Robredo, Patricia, et al.
Publicado: (2017)

Only first intravitreal bevacizumab injection achieves statistically significant visual improvement in naïve myopic choroidal neovascularization
por: Milani, Paolo, et al.
Publicado: (2012)

Matrix Metalloproteinase 10 Contributes to Choroidal Neovascularisation
por: González-Zamora, Jorge, et al.
Publicado: (2022)

Result of intravitreal aflibercept injection for myopic choroidal neovascularization
por: Chen, Shih-Lin, et al.
Publicado: (2021)

Usefulness of Denoising Process to Depict Myopic Choroidal Neovascularisation Using a Single Optical Coherence Tomography Angiography Image
por: Sawai, Yuka, et al.
Publicado: (2020)

Practicability confirmation by meta-analysis of intravitreal ranibizumab compared to photodynamic therapy to treat polypoidal choroidal vasculopathy
por: Liu, Ling, et al.
Publicado: (2015)

Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis
por: Shah, Nikunj J, et al.
Publicado: (2011)

Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis
por: Pandey, Neeraj, et al.
Publicado: (2013)

Macular vortex vein with choroidal neovascularisation in pathologic myopia
por: Schouten, Ike M, et al.
Publicado: (2019)

Intravitreal Bevacizumab for Management of Choroidal Osteoma without Choroidal Neovascularization
por: Najafabadi, Farhad Fazel, et al.
Publicado: (2015)

The Use of Intravitreal Ranibizumab for Choroidal Neovascularization Associated with Vogt-Koyanagi-Harada Syndrome
por: Kolomeyer, A. M., et al.
Publicado: (2011)

Intravitreal bevacizumab (avastin) for circumscribed choroidal hemangioma
por: Mandal, Subrata, et al.
Publicado: (2011)

Application of Intravitreal Bevacizumab for Circumscribed Choroidal Hemangioma
por: Sagong, Min, et al.
Publicado: (2009)

Switching from Intravitreal Ranibizumab to Bevacizumab for Age-Related Macular Degeneration
por: Yamada, Kisaburo, et al.
Publicado: (2011)

Intravitreal bevacizumab-induced exacerbation of proteinuria in diabetic nephropathy, and amelioration by switching to ranibizumab
por: Hanna, Ramy M, et al.
Publicado: (2020)

Intravitreal aflibercept for choroidal neovascularization secondary to angioid streaks in a non-responder to intravitreal ranibizumab
por: Makri, Olga E, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_m6uf4j2gsc55gleehgmrin2gr3